Display options
Cite
Furukawa T, Shimoyama S, Miki Y, et al. Chronic diazepam administration increases the expression of Lcn2 in the CNS. Pharmacol Res Perspect. 2017;5(1):e00283doi: 10.1002/prp2.283.
Furukawa, T., Shimoyama, S., Miki, Y., Nikaido, Y., Koga, K., Nakamura, K., Wakabayashi, K., & Ueno, S. (2017). Chronic diazepam administration increases the expression of Lcn2 in the CNS. Pharmacology research & perspectives, 5(1), e00283. https://doi.org/10.1002/prp2.283
Furukawa, Tomonori, et al. "Chronic diazepam administration increases the expression of Lcn2 in the CNS." Pharmacology research & perspectives vol. 5,1 (2017): e00283. doi: https://doi.org/10.1002/prp2.283
Furukawa T, Shimoyama S, Miki Y, Nikaido Y, Koga K, Nakamura K, Wakabayashi K, Ueno S. Chronic diazepam administration increases the expression of Lcn2 in the CNS. Pharmacol Res Perspect. 2017 Jan 31;5(1):e00283. doi: 10.1002/prp2.283. eCollection 2017 Feb. PMID: 28596835; PMCID: PMC5461642.
Copy Download .nbib Format: NLM
Share it on

Pharmacol Res Perspect. 2017 Jan 31;5(1):e00283. doi: 10.1002/prp2.283. eCollection 2017 Feb.

Chronic diazepam administration increases the expression of Lcn2 in the CNS.

Pharmacology research & perspectives

Tomonori Furukawa, Shuji Shimoyama, Yasuo Miki, Yoshikazu Nikaido, Kohei Koga, Kazuhiko Nakamura, Koichi Wakabayashi, Shinya Ueno

Affiliations

  1. Department of Neurophysiology Hirosaki University Graduate School of Medicine Hirosaki Japan.
  2. Research Center for Child Mental Development Hirosaki University Graduate School of Medicine Hirosaki Japan.
  3. Department of Neuropathology Hirosaki University Graduate School of Medicine Hirosaki Japan.
  4. Department of Neuropsychiatry Hirosaki University Graduate School of Medicine Hirosaki Japan.

PMID: 28596835 PMCID: PMC5461642 DOI: 10.1002/prp2.283

Abstract

Benzodiazepines (BZDs), which bind with high affinity to gamma-aminobutyric acid type A receptors (GABA

Keywords: Benzodiazepine; GABAA‐Rs; Ngal; diazepam; lcn2; transcriptome

References

  1. J Neurosci. 2016 May 18;36(20):5608-22 - PubMed
  2. J Neurosci Res. 2012 Mar;90(3):540-50 - PubMed
  3. Eur J Neurosci. 2006 May;23(9):2495-504 - PubMed
  4. J Neurosci. 2002 Jul 1;22(13):5572-80 - PubMed
  5. PLoS One. 2012;7(8):e43054 - PubMed
  6. Neuropharmacology. 1996;35(9-10):1457-63 - PubMed
  7. Annu Rev Cell Dev Biol. 1995;11:355-77 - PubMed
  8. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006391 - PubMed
  9. Neurosci Lett. 2016 Feb 2;613:41-6 - PubMed
  10. BMJ. 2014 Sep 09;349:g5312 - PubMed
  11. J Neurochem. 2007 Dec;103(6):2518-28 - PubMed
  12. Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):4069-74 - PubMed
  13. Nat Rev Drug Discov. 2011 Jul 29;10(9):685-97 - PubMed
  14. Curr Opin Neurobiol. 2003 Jun;13(3):341-7 - PubMed
  15. J Neurochem. 2015 Mar;132(6):622-8 - PubMed
  16. Proc Natl Acad Sci U S A. 1988 Dec;85(23):9336-40 - PubMed
  17. Neuropharmacology. 2009 Jun;56(8):1124-30 - PubMed
  18. Psychopharmacology (Berl). 2014 Aug;231(15):2967-79 - PubMed
  19. J Recept Signal Transduct Res. 2006;26(5-6):731-40 - PubMed
  20. Oral Microbiol Immunol. 1990 Oct;5(5):256-62 - PubMed
  21. Neurosci Biobehav Rev. 2015 Feb;49:135-56 - PubMed
  22. J Neurosci. 1989 Oct;9(10):3577-83 - PubMed
  23. J Biol Chem. 2006 Sep 1;281(35):25703-11 - PubMed
  24. Behav Brain Res. 2003 Sep 15;144(1-2):119-24 - PubMed
  25. Arthritis Rheum. 2013 Apr;65(4):1064-73 - PubMed
  26. Hippocampus. 1994 Feb;4(1):19-35 - PubMed
  27. Curr Drug Targets CNS Neurol Disord. 2003 Aug;2(4):233-9 - PubMed
  28. Nat Med. 2006 Sep;12(9):1048-55 - PubMed
  29. Glia. 1993 Jan;7(1):111-8 - PubMed
  30. Brain Behav Immun. 2016 Jan;51:154-168 - PubMed
  31. Trends Pharmacol Sci. 1997 Nov;18(11):425-9 - PubMed
  32. Neuropharmacology. 2009 Oct-Nov;57(5-6):481-95 - PubMed
  33. Pharmacol Ther. 2002 Apr-May;94(1-2):113-22 - PubMed
  34. J Neurosci Res. 2014 Aug;92(8):1054-61 - PubMed
  35. FASEB J. 2012 Jul;26(7):2811-23 - PubMed
  36. Cell. 2005 Dec 29;123(7):1293-305 - PubMed
  37. Mayo Clin Proc. 1993 Aug;68(8):731-7 - PubMed
  38. Psychol Med. 1988 May;18(2):365-74 - PubMed
  39. Eur J Neurosci. 1991;3(4):310-316 - PubMed
  40. Ann N Y Acad Sci. 1999 Apr 30;868:645-53 - PubMed
  41. Stroke. 2014 Jul;45(7):2085-92 - PubMed
  42. Pharmacol Res Perspect. 2017 Jan 31;5(1):e00283 - PubMed
  43. J Clin Psychopharmacol. 2002 Jun;22(3):285-93 - PubMed
  44. J Neurochem. 2004 Mar;88(5):1059-67 - PubMed
  45. Mol Metab. 2013 May 09;2(3):161-70 - PubMed
  46. ASN Neuro. 2014 Jan 30;6(1):e00136 - PubMed
  47. Acta Neurochir Suppl. 2016;121:291-4 - PubMed
  48. J Immunol. 2013 Nov 15;191(10):5204-19 - PubMed
  49. Neuropharmacology. 2008 Feb;54(2):309-18 - PubMed
  50. Curr Opin Neurobiol. 2012 Jun;22(3):552-8 - PubMed
  51. Drug Saf. 2015 Oct;38(10):909-19 - PubMed
  52. Glia. 2012 Jul;60(7):1145-59 - PubMed
  53. Pharmacol Rev. 1995 Jun;47(2):181-234 - PubMed
  54. Brain Res. 2013 Apr 10;1505:86-92 - PubMed
  55. J Biol Chem. 2007 Jun 15;282(24):17855-65 - PubMed
  56. Int J Geriatr Psychiatry. 2012 Dec;27(12):1248-57 - PubMed
  57. Cell. 2005 Dec 29;123(7):1175-7 - PubMed
  58. J Neurosci. 1990 Jul;10(7):2330-7 - PubMed
  59. Synapse. 1999 Mar 15;31(4):263-77 - PubMed
  60. Curr Opin Genet Dev. 1992 Apr;2(2):199-204 - PubMed
  61. World J Biol Psychiatry. 2008;9(4):248-312 - PubMed
  62. J Immunol. 2007 Sep 1;179(5):3231-41 - PubMed
  63. J Physiol. 2013 Aug 15;591(16):3901-17 - PubMed

Publication Types